Frequent Q&A

Q: What is the actual product or service that BioNAV offers?
A: BioNAV licenses its patent-pending Air Particle Identification (ID) process to manufacturers and software developers through annual user subscription agreements. These licenses provide legal authorization to integrate BioNAV’s methodology into air-handling products or analytical platforms. In addition to licensing, BioNAV offers strategic advisory services and referral support. Licensed manufacturers can transmit analyzed particle data to BioNAV’s PatientShare platform, enabling end users to monitor their environmental exposure and optionally share that information with healthcare providers.
 

Q: What manufacturers does BioNAV support?
A: BioNAV’s technology is applicable to a wide range of manufacturers involved in air filtration or controlled air/gas systems. This includes industries focused on residential, commercial, medical, transportation, industrial, and military environments where air quality and particulate analysis are essential.
 

Q: What products will BioNAV’s technology work with?
A: BioNAV’s process is most commonly implemented in air filtration-based products, including HVAC systems, vehicle and aircraft cabin filters, vacuum systems, and vented appliances. The technology is also compatible with advanced scientific instruments. While traditionally applied to particles captured by airflow, our process extends to the analysis of particles collected via gravity, static charge, atmospheric pressure, chemical or biological reactions, and other physical mechanisms. BioNAV supports a variety of image capture technologies, including optical microscopy, laser-based systems, radar, UV, infrared, and spectrographic imaging.
 

Q: How would my company benefit from implementing BioNAV's technology?
A: Integrating BioNAV’s process provides manufacturers with a novel data layer that enhances product differentiation and customer value. The required data-sharing links support internal functions such as product development, quality assurance, and environmental diagnostics. Additionally, manufacturers may choose to deliver real-time particle classification alerts through their own applications. BioNAV’s PatientShare app can also aggregate data across different product ecosystems (brands) used by the same end-user, offering continuity of environmental tracking. This functionality opens potential new revenue channels and provides customers with tools to support proactive respiratory care.
 

Q: What is BioNAV’s Proof-of-Concept (PoC) program?
A: BioNAV offers a structured Proof-of-Concept program for manufacturers seeking to validate the integration of our Air Particle ID process. The program allows companies to assess the compatibility of their vision systems, AI/ML infrastructure, and data outputs within the BioNAV ecosystem. Participation is subject to qualification to ensure no conflict with BioNAV’s intellectual property. During the PoC phase, licensing fees may be deferred until technical and commercial viability is confirmed and a formal go-to-market strategy is in place.
 

Q: What’s the cost to join the PoC?
A: Pricing for pilot programs is determined based on usage metrics. We recommend scheduling a discovery meeting with the BioNAV team to assess your system architecture and define an appropriate scope of testing.
 

Q: Does BioNAV support input data from multiple products in different environments?
A: Yes. BioNAV is designed to aggregate particle analysis data from multiple licensed devices under a unified user profile. This data can be accessed and managed via the BioNAV mobile and desktop apps, which will also support integration with third-party applications—such as weather or allergy reports—and user-supplied health information. This enables users to compile a comprehensive view of environmental exposure across various daily settings, which can then be shared with healthcare providers.
 

Q: How does BioNAV send the end-user’s analyzed data to healthcare providers?
A: Data is transmitted through the BioNAV PatientShare API, which enables secure sharing of analyzed air quality data. With user consent, the information can be forwarded directly to healthcare providers or reviewed in person during clinical visits. The PatientShare mobile and desktop applications are currently in development, with beta release targeted for the second half of 2026. BioNAV is also exploring integration with Electronic Health Record (EHR) systems for streamlined clinical workflows.